Halia Therapeutics Announces Positive Phase 1 Clinical Trial Results for HT-6184 at the 5th Inflammasome Therapeutics Summit
LEHI, Utah, Nov. 29, 2023 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical company pioneering a novel class of small molecule medications designed to combat inflammation, today announced positive results following the successful...
David Bearss’ passion for drug discovery has guided his noteworthy career as a dynamic leader who integrates scientific and business interests to deliver new medicines to patients. That passion is still evident today as he gives back to the industry he loves, making a difference with bold initiatives to improve health and change the face of Utah’s life sciences ecosystem.
Halia Therapeutics has a new lab in Lehi and believes it is on the forefront of research to target chronic inflammation to treat neurodegeneration and inflammatory diseases.
Thanks to Salt Lake City’s FOX 13 News for attending and reporting on Halia Therapeutics’ grand opening. This report aired August 23, 2013.
Closely-held Halia Therapeutics is developing a broad pipeline of novel therapies that are essential mediators of immune cell signaling with the potential to improve the lives of patients with inflammatory disorders and neurological diseases.
Read the entire article at: www.bioworld.com/articles/699721-in-the-clinic-for-aug-8-2023
https://podcasts.apple.com/us/podcast/episode-37-david-bearss-ph-d-president-and-ceo-of/id1648796570?i=1000616814121 David Bearss, President and CEO of Halia Therapeutics, and Todd Kays, Vice President of Dermatology at Vile Health Technologies, discuss the connection...
Halia Therapeutics – Eliminating Chronic Inflammation by Targeting the NLRP3 Inflammasome Dr. David Bearss, PhD, President and CEO at Halia Therapeutics, a clinical-stage biopharma company developing novel therapies to improve the lives of patients with inflammatory...
We are proud to announce that Halia CEO David Bearss Ph.D. will be awarded the 2023 Governor’s Medal for Science and Technology on May 2nd at the One Utah Summit. https://business.utah.gov/news/recipients-of-the-2023-utah-governors-science-medals-announced/
The Bio Report David Bearss Ph.D., president and CEO of Halia Therapeutics, Inc., discusses with Daniel Levine the NLRP3 inflammasome, the role it plays in Alzheimer’s disease and other neurologic conditions, and the case for the company's therapeutic approach....
Empowered Patient Podcast David Bearss the Co-Founder, CEO and President of Halia Therapeutics, points out that despite traditional thinking, chronic inflammation is not just an unresolved acute inflammatory response. It has been discovered that a different pathway...
BioSpace Biopharma Execs Adopt Creative Mindset at BIO CEO https://www.biospace.com/article/biopharma-execs-adopt-creative-mindset-at-bio-ceo-/
STAT Up and down the ladder: The latest comings and goings https://www.statnews.com/pharmalot/2023/01/20/pharma-jobs-dianthus-catalent-cytovance/
Fierce Biotech Chutes & Ladders—David Kessler resigns from the Biden admin, marking the unofficial end of Operation Warp Speed https://www.fiercebiotech.com/biotech/chutes-ladders-david-kessler-resigns-biden-admin-marking-unofficial-end-operation-warp
Endpoints News 'Perfect time': SIGA's CEO on retirement; Juvenescence woos GSK vet to lead anti-aging play https://endpts.com/biopharma-jobs-report-perfect-time-sigas-ceo-on-retirement-juvenescence-woos-gsk-vet-to-lead-anti-aging-play/
The Pharma Letter Amgen’s Margit Janát-Amsbury named Halia CMO https://www.thepharmaletter.com/article/amgen-s-margit-janat-amsbury-named-halia-cmo
BioWorld Appointments and advancements for Jan. 19, 2023 https://www.bioworld.com/articles/693419-appointments-and-advancements-for-jan-19-2023?v=preview
CFO DIVE Biotech CFOs sharpen financing tactics for lean times https://www.cfodive.com/news/3-biotech-cfos-finding-financing-lean-times/640301/
David J. Bearss, Ph.D., Co-Founder, and CEO of Salt Lake City-based Halia Therapeutics, for his limitless and inspiring entrepreneurial spirit, mentorship, and achievements that are transforming therapeutics, spawning discovery, seeding startups, and strengthening...